Year All202620252024202320222021202020192018201720162015201420132012201120102007 01.11.11 Syndax Announced Publication of Entinostat NSCLC Data in Cancer Research Read More 01.04.11 Syndax Pharmaceuticals to Present at Biotech Showcase 2011 Read More 12.10.10 Syndax Pharmaceuticals' Entinostat in Combination Shows Activity in Breast Cancer Read More 12.09.10 Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients Phase 2 data to be presented at 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology Read More 11.10.10 Syndax Pharmaceuticals to Present at Lazard Annual Healthcare Conference Read More 10.15.10 Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat--Patent issuance extends entinostat exclusivity to 2029-- Read More 09.28.10 Syndax Pharmaceuticals to Present at BIO Investor Forum Read More 09.22.10 Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum Read More 09.16.10 Syndax Pharmaceuticals to Present at UBS 2010 Global Life Sciences Conference Read More 09.09.10 Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010 Read More 08.11.10 Syndax Pharmaceuticals raises $6 Million in Securities Offering - Funding to Support Completion of Randomized Phase 2 Breast Cancer Study in First Half 2011- Read More 06.04.10 Syndax Pharmaceuticals' Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer - Data to be presented at the American Society of Clinical Oncology annual meeting – Read More
12.09.10 Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients Phase 2 data to be presented at 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology Read More
10.15.10 Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat--Patent issuance extends entinostat exclusivity to 2029-- Read More
09.09.10 Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010 Read More
08.11.10 Syndax Pharmaceuticals raises $6 Million in Securities Offering - Funding to Support Completion of Randomized Phase 2 Breast Cancer Study in First Half 2011- Read More
06.04.10 Syndax Pharmaceuticals' Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer - Data to be presented at the American Society of Clinical Oncology annual meeting – Read More